- Home
- CEV vs PTHL Comparison
CEV vs PTHL Comparison
Compare CEV & PTHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEV
- PTHL
- Stock Information
- Founded
- CEV 1999
- PTHL 1998
- Country
- CEV United States
- PTHL China
- Employees
- CEV N/A
- PTHL N/A
- Industry
- CEV Finance/Investors Services
- PTHL
- Sector
- CEV Finance
- PTHL
- Exchange
- CEV Nasdaq
- PTHL Nasdaq
- Market Cap
- CEV 75.9M
- PTHL 65.0M
- IPO Year
- CEV N/A
- PTHL 2024
- Fundamental
- Price
- CEV $10.07
- PTHL $4.17
- Analyst Decision
- CEV
- PTHL
- Analyst Count
- CEV 0
- PTHL 0
- Target Price
- CEV N/A
- PTHL N/A
- AVG Volume (30 Days)
- CEV 19.6K
- PTHL 45.8K
- Earning Date
- CEV 01-01-0001
- PTHL 02-11-2025
- Dividend Yield
- CEV 4.23%
- PTHL N/A
- EPS Growth
- CEV N/A
- PTHL N/A
- EPS
- CEV 0.36
- PTHL N/A
- Revenue
- CEV N/A
- PTHL $572,291.00
- Revenue This Year
- CEV N/A
- PTHL N/A
- Revenue Next Year
- CEV N/A
- PTHL N/A
- P/E Ratio
- CEV $29.36
- PTHL N/A
- Revenue Growth
- CEV N/A
- PTHL 2.32
- 52 Week Low
- CEV $8.83
- PTHL $3.32
- 52 Week High
- CEV $10.91
- PTHL $6.45
- Technical
- Relative Strength Index (RSI)
- CEV 25.32
- PTHL N/A
- Support Level
- CEV $10.40
- PTHL N/A
- Resistance Level
- CEV $10.75
- PTHL N/A
- Average True Range (ATR)
- CEV 0.09
- PTHL 0.00
- MACD
- CEV -0.06
- PTHL 0.00
- Stochastic Oscillator
- CEV 0.00
- PTHL 0.00
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.
About PTHL Pheton Holdings Ltd Class A Ordinary Shares
Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.